Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1256222Generated: October 31, 2026

Sodium Hydroxide → 5-(2,6-difluorophenyl)-3-{[1-(trifluoromethanesulphonyl)piperidin-4-yl]amino}-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazolo[4,3-c]isoquinoline-7-carboxamide

https://huagongshe.com/reaction/1256222

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium HydroxideHCID 14798—
ReactantAmmonium ChlorideHCID 25517—
Reactant1-HydroxybenzotriazoleHCID 75771—
ReactantDiisopropylethylamineHCID 81531—
ReactantMonobasic potassium phosphateHCID 516951—
ReactantHCID 66774364HCID 66774364—
ReactantHCID 86664929HCID 86664929—
SolventEthanolHCID 702—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
SolventTetrahydrofuranHCID 8028—
Product5-(2,6-difluorophenyl)-3-{[1-(trifluoromethanesulphonyl)piperidin-4-yl]amino}-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazolo[4,3-c]isoquinoline-7-carboxamideHCID 66774639—

Reaction Steps

A 30 ml round-bottomed flask equipped with a magnetic stirrer and with a septum having a top-mounted argon intake is charged with 272 mg of 5-(2,6-difluorophenyl)-3-{[1-(trifluoromethanesulphonyl)piperidin-4-yl]amino}-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazolo[4,3-c]isoquinoline-7-carbonitrile, 10 ml of ethanol, 5 ml of THF and 0.611 ml of 9.3N NaOH. After 2 h of reflux, the mixture is cooled, and 50 ml of a 1M aqueous solution of potassium dihydrogen phosphate are poured in. The product is extracted with AcOEt, washed with saturated aqueous NaCl solution, dried over MgSO4, filtered and concentrated to dryness under RP. The crude solid obtained is dissolved in 4 ml of DMF and than 275 mg of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluoride (BOP), 84 mg of 1-hydroxybenzotriazole (HOBT), 44 mg of ammonium chloride and 2 ml of N,N-diisopropylethylamine (DIPEA) are added. After 3 h at RT, the mixture is poured into water, extracted with AcOEt, and washed with saturated aqueous NaCl solution. Drying of MgSO4, filtering and concentration under RP give 300 mg of 5-(2,6-difluorophenyl)-3-{[1-(trifluoromethanesulphonyl)piperidin-4-yl]amino}-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazolo[4,3-c]isoquinoline-7-carboxamide. MS (E/I): m/z=684 (M+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08461175B2
Source datasetuspto-grants-2013_06
ORD IDord-ed3fbfc864514a93af789e18b8184456
Source noteuspto-grants-2013_06